Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies
- 1.2k Downloads
This study examined the experience and coping strategies for taste alteration in female breast cancer patients treated with docetaxel or paclitaxel.
A purposive sample of 25 patients currently receiving docetaxel or paclitaxel or within 6 months of having completed treatment was recruited. Semi-structured interviews and patient-level data were utilized for this exploratory descriptive study. Interview data were analyzed with the constant comparative method; patient-level data were abstracted from the electronic medical record.
Of all side effects reported from taxanes, the most common was taste alteration (8 of 10 docetaxel patients, 3 of 15 paclitaxel patients). Women that experience taste alteration chose not to eat as much, ate on an irregular schedule, and/or lost interest in preparing meals for themselves and/or their family. Women adopted a variety of new behaviors to deal with the taste alteration and its effects, including trying new recipes, eating strongly flavored foods, honoring specific food cravings, eating candy before meals, cutting food with lemon, drinking sweetened drinks, using plastic eating utensils, drinking from a straw, brushing their teeth and tongue before meals, and using baking soda and salt wash or antibacterial mouthwash.
Taste alteration affects breast cancer patients’ lives, and they develop management strategies to deal with the effect. While some self-management strategies can be seen as positively adaptive, the potential for increased caloric consumption and poor eating behaviors associated with some coping strategies may be a cause for concern given the observation of weight gain during breast cancer treatment and association of obesity with poor treatment outcomes in breast cancer patients. Further studies are warranted to determine the overall burden of this symptom and measurement of cancer and non-cancer-related consequences of these behavioral adaptations.
KeywordsChemotherapy Breast cancer Taste Dysgeusia
Conflicts of interest
The authors declare they have no conflict of interest to report in relationship to this manuscript.
- 17.Maxwell J (1997) Designing a qualitative study. In: Bickman L, Rog DJ (eds) Handbook of applied social research methods. Sage, Thousand Oaks, pp 69–100Google Scholar
- 18.Patton M (2002) Qualitative research and evaluation methods. Sage, LondonGoogle Scholar
- 19.Speck RM, Demichele A, Farrar JT, et al. (2012) Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Support Care Cancer Jan 11 [Epub ahead of print]Google Scholar
- 20.QSR International (2008) Nvivo qualitative data analysis software, (ed version 8). QSR International Pty LtdGoogle Scholar
- 22.Velos I (2011) Velos eResearch. Velos, Inc., FremontGoogle Scholar
- 23.Macquart-Moulin G, Viens P, Palangie T et al (2000) High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? J Clin Oncol 18:754–764PubMedGoogle Scholar
- 25.Hernandez BM, Bonomi P, Hoeltgen T (1983) Weight gain during adjuvant chemotherapy for stage II breast cancer. Proc Am Soc Clin Oncol 2:108Google Scholar
- 29.Janni JW, Hepp PGM, Andergassen U et al (2011) Final multivariate analysis of obesity and survival in patients with node-positive primary breast cancer: the ADEBAR trial. J Clin Oncol 29:abstr 1020Google Scholar
- 30.Gluz O, Liedtke C, Kates RE et al (2011) Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): pooled analysis from the WSG AM-01 and -02 trials. J Clin Oncol 29:abstr 1021Google Scholar
- 31.Hepp PGM, Rack B, Annecke K, et al. (2010) Multivariate analysis of obesity and disease free survival in patients with nodal positive primary breast cancer—the ADEBAR Trial. San Antonio Breast Cancer Symposium, 2010. http://www.success-studie.de/portal/publikationen/2010/Hepp_SABCS_vortrag2010.pdf Accessed 3 March 2012
- 33.de Azambuja E, McCaskill-Stevens W, Francis P et al (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat 119:145–153PubMedCrossRefGoogle Scholar
- 34.Sparano JA, Wang M, Martino S, et al. (2010) Obesity at diagnosis is associated with inferior outcomes in hormone receptor positive breast cancer. San Antonio Breast Cancer Symp, 2010: abstr S2-1Google Scholar
- 37.National Cancer Institute (2009) Common terminology criteria for adverse events v4.0. NCI, NIH, DHHS. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf Accessed 10 August 2011